Clin2
NCT04800588Possibly a fitRecruiting

Computer tests to study early Alzheimer’s changes

Alzheimer DiseaseCognitive DeclineAging

Part of Brain & nervous system, Mental health clinical trials.

This study uses computer and touch-screen tasks to measure thinking changes in people who may be in the early, symptom-free stage of Alzheimer’s disease. It aims to understand how these brain-related changes show up on testing, which could help future detection or tracking.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
18 years to 89 years
Study type
Interventional

Who can take part

  • You can use a computer mouse and a touch screen
  • You speak English as your main language
  • If you join Spanish materials, you speak Spanish as your main language
  • You do not have a history of psychiatric disorders
  • You do not have depression or anxiety

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07272811Recruiting
Computer memory testing for early Alzheimer's signs

This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.

Milan, Italy
NCT05194787Recruiting
Online tests to spot early Alzheimer’s changes

This study looks at whether online motor (movement) and thinking tasks can detect early changes related to Alzheimer’s disease. You may be able to take part if you’re over 50 and do not already have a diagnosis of dementia.

Hobart, Tasmania
NCT07041450Recruiting
Screening for Alzheimer's treatment using digital tests and blood tests

This study is testing whether simple digital memory tests and blood tests can help find people who might qualify for anti-amyloid treatments (medications that target Alzheimer's-related proteins). It aims to make screening easier and faster, without needing a spinal tap or PET scan.

Greenfield Park, Quebec
NCT04575337Recruiting
Biomarker study to help detect Alzheimer’s early

This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.

Beijing, Beijing Municipality
NCT07521722Not yet recruiting
Blood Tests for Alzheimer's Risk in Healthy Adults

This research study tests new blood tests that may detect early signs of Alzheimer's disease in people who currently have normal thinking and memory. By participating, you help researchers understand who might be at risk and develop better ways to predict the disease early.

Barcelona
NCT05614310Recruiting
Brain scan study to spot early Alzheimer’s

This study uses MRI brain scans and memory tests to help detect early Alzheimer’s disease. It compares people with Alzheimer’s (diagnosed by a clinician) with people without memory problems to see which scan and test results stand out.

Aberdeen

Hear when a new Cognitive Decline trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.